Enhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer

被引:10
作者
Pang, Jun [1 ]
Gao, Xin [1 ]
Liu, Xiaopeng [1 ]
Wang, Kebing [1 ]
Zhang, Yan [1 ]
Feng, Lianqiang [2 ]
Zhan, Hailun [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 51063, Peoples R China
[2] Sun Yat Sen Univ, Basic Med Inst, Dept Immunol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
dendritic cells; cytokine-induced killer cells; hormone-refractory prostate cancer; immunotherapy;
D O I
10.1080/07357900701511789
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
In this study, we evaluated antitumor effects of allotumour RNA-transfected dendritic cells (DCs) cocultured with autologous cytokine-induced killer cells (CIKs) on hormone-refractory prostate cancer. The cocultured cells enhanced prostate cancer cytolysis from 26% (CIKs-induced cytolysis) to 80.8%. They also increased the productions of CD4(+) Th1 (IFN-gamma+IL-4(-), 55.52%) and CD8(+) T (IFN-gamma(+), 69.59%) cells determined by intracellular cytokines IFN-gamma/IL-4 staining and reduced the rate of CD4(+)CD25(+) cells from 18.72% (in CIKs) to 9.72%. The cocultured cells significantly inhibited tumor growth in SCID mouse and induced cancer cells necrosis and apoptosis. Our study indicates that tumor RNA-pulsed DCs cocultured with autologous CIKs significantly enhance antitumor immunity, which can be induced by increased CD4(+) Th1 and CD8(+) T cells and decreased CD4(+)CD25(+) regulatory T (T-reg) cells. This provides a potential immunotherapy strategy for HRPC.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 31 条
[1]
Aalamian M, 2001, PROSTATE, V46, P68
[2]
Almand B, 2000, CLIN CANCER RES, V6, P1755
[3]
Dendritic cells directly trigger NK cell functions:: Cross-talk relevant in innate anti-tumor immune responses in vivo [J].
Fernandez, NC ;
Lozier, A ;
Flament, C ;
Ricciardi-Castagnoli, P ;
Bellet, D ;
Suter, M ;
Perricaudet, M ;
Tursz, T ;
Maraskovsky, E ;
Zitvogel, L .
NATURE MEDICINE, 1999, 5 (04) :405-411
[4]
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells:: Results of a Phase I clinical trial [J].
Fuessel, Susanne ;
Meye, Axel ;
Schmitz, Marc ;
Zastrow, Stefan ;
Linne, Clemens ;
Richter, Katja ;
Loebel, Barbel ;
Hakenberg, Oliver W. ;
Hoelig, Kristina ;
Rieber, E. Peter ;
Wirth, Manfred P. .
PROSTATE, 2006, 66 (08) :811-821
[5]
Cancer immunotherapy with mRNA-transfected dendritic cells [J].
Gilboa, E ;
Vieweg, J .
IMMUNOLOGICAL REVIEWS, 2004, 199 (01) :251-263
[6]
Patient-derived dendritic cells transduced with an α-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells [J].
González-Carmona, MA ;
Märten, A ;
Hoffmann, P ;
Schneider, C ;
Sievers, E ;
Schmidt-Wolf, IGH ;
Sauerbruch, T ;
Caselmann, WH .
LIVER INTERNATIONAL, 2006, 26 (03) :369-379
[7]
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes [J].
Grünebach, F ;
Müller, MR ;
Nencioni, A ;
Brossart, P .
GENE THERAPY, 2003, 10 (05) :367-374
[8]
Heiser A, 2001, CANCER RES, V61, P3388
[9]
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA [J].
Heiser, A ;
Maurice, MA ;
Yancey, DR ;
Wu, NZ ;
Dahm, P ;
Pruitt, SK ;
Boczkowski, D ;
Nair, SK ;
Ballo, MS ;
Gilboa, E ;
Vieweg, J .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :2953-2960
[10]
Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30